Oncology & Cancer

Neoadjuvant immunotherapy improves outlook in high-risk melanoma

Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...

Oncology & Cancer

New clinical guideline on radiation therapy for IDH-mutant glioma

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse ...

page 2 from 6